Total Payments
$1,191
2024 Payments
$92.11
Companies
14
Transactions
78
Medicare Patients
852
Medicare Billing
$38,615
Payment Breakdown by Category
Food & Beverage$1,191 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,191 | 78 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $639.51 | 41 | $0 (2024) |
| Novo Nordisk Inc | $224.21 | 19 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $49.13 | 3 | $0 (2021) |
| IBSA Pharma Inc. | $41.12 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $39.93 | 2 | $0 (2022) |
| MannKind Corporation | $36.42 | 2 | $0 (2021) |
| Lilly USA, LLC | $36.01 | 2 | $0 (2023) |
| Medtronic, Inc. | $27.68 | 1 | $0 (2023) |
| Amgen Inc. | $22.30 | 1 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $19.46 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $92.11 | 5 | ABBVIE INC. ($39.35) |
| 2023 | $175.51 | 9 | Novo Nordisk Inc ($53.09) |
| 2022 | $378.79 | 23 | ABBVIE INC. ($339.67) |
| 2021 | $544.91 | 41 | AbbVie Inc. ($238.10) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: UROLOGY | ||||||
| 03/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diabetes | ||||||
| 01/11/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/09/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes | ||||||
| 11/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Diabetes | ||||||
| 08/30/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/16/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/02/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| Category: non-opioid analgesic | ||||||
| 06/23/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| Category: non-opioid analgesic | ||||||
| 06/06/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Diabetes | ||||||
| 04/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: DIABETES | ||||||
| 07/07/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Diabetes | ||||||
| 06/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 131 | 263 | $18,099 | $4,965 |
| 2022 | 9 | 225 | 374 | $27,891 | $9,233 |
| 2021 | 4 | 88 | 95 | $16,668 | $6,299 |
| 2020 | 12 | 408 | 672 | $45,953 | $18,118 |
Total Patients
852
Total Services
1,404
Medicare Billing
$38,615
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 40 | $9,040 | $2,794 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 37 | $5,698 | $1,835 | 32.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 33 | $1,452 | $255.36 | 17.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 65 | $325.00 | $47.25 | 14.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 19 | 88 | $1,584 | $34.03 | 2.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 43 | 43 | $10,363 | $4,204 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 40 | $9,040 | $2,766 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 19 | $2,926 | $1,014 | 34.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 36 | 36 | $1,512 | $486.28 | 32.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 23 | 37 | $1,628 | $304.50 | 18.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 15 | 41 | $529.72 | $196.97 | 37.2% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 18 | 18 | $360.00 | $164.21 | 45.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 18 | 76 | $380.00 | $70.35 | 18.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 15 | 64 | $1,152 | $25.60 | 2.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 26 | 26 | $6,266 | $2,792 | 44.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 28 | $6,328 | $2,121 | 33.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 21 | $3,234 | $1,089 | 33.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 20 | 20 | $840.00 | $296.60 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 69 | 69 | $12,568 | $6,424 | 51.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 62 | 74 | $12,189 | $4,918 | 40.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 55 | 74 | $8,227 | $3,450 | 41.9% |
| 86328 | Ia nfct ab sarscov2 covid19 | Office | 2020 | 13 | 13 | $910.00 | $587.99 | 64.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 38 | 61 | $2,222 | $506.50 | 22.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 35 | 35 | $976.00 | $505.29 | 51.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 19 | 21 | $1,267 | $500.13 | 39.5% |
About Brittany Lambert, CRNP
Brittany Lambert, CRNP is a Family healthcare provider based in Scottsboro, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1861926842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brittany Lambert, CRNP has received a total of $1,191 in payments from pharmaceutical and medical device companies, with $92.11 received in 2024. These payments were reported across 78 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,191).
As a Medicare-enrolled provider, Lambert has provided services to 852 Medicare beneficiaries, totaling 1,404 services with total Medicare billing of $38,615. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Scottsboro, AL
- Active Since 04/17/2017
- Last Updated 04/17/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1861926842
Products in Payments
- VRAYLAR (Drug) $204.59
- UBRELVY (Drug) $166.63
- QULIPTA (Drug) $165.47
- Ozempic (Drug) $139.55
- LINZESS (Drug) $85.23
- RYBELSUS (Drug) $62.19
- Edarbyclor (Drug) $49.13
- LICART (Drug) $41.12
- JARDIANCE (Drug) $39.93
- AFREZZA (Drug) $36.42
- MOUNJARO (Drug) $36.01
- INTELLIS ADAPTIVESTIM (Device) $27.68
- Rybelsus (Drug) $22.47
- Otezla (Drug) $22.30
- GEMTESA (Drug) $19.46
- CREON (Drug) $17.59
- INJECTAFER (Drug) $15.14
- Azstarys (Drug) $15.09
- SEGLENTIS (Drug) $13.18
- Fycompa (Drug) $12.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Scottsboro
James Blackwood, Fnp-C, FNP-C
Family — Payments: $4,999
Family $4,999
Lindsey White, Np-C, NP-C
Family — Payments: $4,815
Family $4,815
Heather Willmon, Crnp, CRNP
Family — Payments: $2,809
Family $2,809
Kaitlyn Bennett, Np, NP
Family — Payments: $1,764
Family $1,764
Coty Phillips Johnson, Crnp, CRNP
Family — Payments: $949.54
Family $949.54
Jana Jackson, Crnp, CRNP
Family — Payments: $578.13
Family $578.13